当前位置: X-MOL 学术Int. J. Food Sci. Nutr. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Myo-inositol supplementation to prevent gestational diabetes in overweight non-obese women: bioelectrical impedance analysis, metabolic aspects, obstetric and neonatal outcomes – a randomized and open-label, placebo-controlled clinical trial
International Journal of Food Sciences and Nutrition ( IF 3.5 ) Pub Date : 2020-11-25 , DOI: 10.1080/09637486.2020.1852191
Salvatore Giovanni Vitale 1 , Francesco Corrado 2 , Salvatore Caruso 1 , Antonino Di Benedetto 3 , Loretta Giunta 3 , Antonio Cianci 1 , Rosario D'Anna 2
Affiliation  

Abstract

This study aims to evaluate the effects of myo-inositol supplementation on gestational diabetes mellitus (GDM) rates and body water distribution in overweight non-obese women. 223 overweight non-obese women pregnant were randomly assigned to the treatment group (2 g of myo-inositol plus 200 µg of folic acid) or to the placebo one (200 µg of folic acid). The treatment lasted until three weeks after delivery. A tetrapolar impedance analyser was used to study body composition. The incidence of GDM was significantly reduced in the myo-inositol group compared with the placebo group. There was a significant increase in TBW, ECW and ICW values in the placebo group compared to the myo-inositol group. We have recorded a significant reduction in the overall incidence of pregnancy-induced hypertension in the myo-inositol group compared with the placebo group. Our results demonstrate the effectiveness of myo-inositol supplementation in preventing GDM in overweight non-obese pregnant women.



中文翻译:

肌醇补充剂预防超重非肥胖女性妊娠糖尿病:生物电阻抗分析、代谢方面、产科和新生儿结局——一项随机、开放标签、安慰剂对照的临床试验

摘要

本研究旨在评估肌醇补充剂对超重非肥胖女性妊娠期糖尿病 (GDM) 发生率和体内水分分布的影响。223 名超重非肥胖孕妇被随机分配到治疗组(2 克肌醇加 200 微克叶酸)或安慰剂组(200 微克叶酸)。治疗持续到分娩后三周。使用四极阻抗分析仪来研究身体成分。与安慰剂组相比,肌醇组 GDM 的发生率显着降低。与肌醇组相比,安慰剂组的 TBW、ECW 和 ICW 值显着增加。我们记录到,与安慰剂组相比,肌醇组妊娠高血压的总体发病率显着降低。

更新日期:2020-11-25
down
wechat
bug